ChartRow logo
Data provided bySource: Twelve Data
ARMK
$56.58+2.19%
as of close, Nov 17, 2026
☾ AH $56.58 +2.19%
PeersULSRTORBACPRTGPNCTAS
Share this page

ARMK financial statements

The full income statement, balance sheet, and cash-flow statement for Aramark (ARMK), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Financial overview#

Revenue

5Y CAGR +7.6%10Y CAGR +2.6%YoY +9.3%
$19.8B TTM$5.1B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Gross profit

5Y CAGR +7.8%5Y CAGR +7.8%YoY −10.0%
— FY25— Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

5Y n/m10Y CAGR +2.3%YoY +18.1%
$870.7M TTM$215.6M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

5Y n/m10Y CAGR +3.3%YoY +36.0%
$382.9M TTM$97.7M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y n/m10Y CAGR +2.4%YoY +33.3%
$1.43 TTM$0.36 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating cash flow

5Y CAGR +39.1%10Y CAGR +1.4%YoY +52.8%
$921M FY25$117.2M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Capital expenditure

5Y CAGR +3.2%10Y CAGR −0.7%YoY +0.9%
$478M TTM$112.4M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y n/m10Y CAGR +4.5%YoY n/m
$431.8M FY25$4.8M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Shares (diluted)

5Y +6.2%10Y +8.4%YoY +1.2%
267.3M TTM268.5M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Dividend per share

5Y CAGR −0.9%10Y CAGR +2.1%YoY +14.3%
$0.46 TTM$0.12 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Every ARMK chart on Trends →

Shares outstanding (point-in-time)

2024-06 263.4M2024-09 263.9M2024-12 265.1M2025-03 262.1M2025-06 262.9M2025-10 262.9M2026-01 262.8M2026-04 263.0M2026-07 263.6M+0.1% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofOct 3 ’25as ofSep 27 ’24as ofSep 29 ’23as ofSep 30 ’22as ofOct 1 ’21
Revenue18.5B+6.4%17.4B+8.2%16.1B+17.5%13.7B+13.2%12.1B-5.7%
————1.09B+30.3%
Cost of revenue———14.8B+34.2%11.0B-8.2%
Selling, general & administrative278M-1.8%284M+3.6%274M+5.9%258M-25.5%347M+12.9%
Restructuring36.4M+84.8%19.7M-39.0%32.3M——
Amortization of intangibles125M+16.3%107M+19.7%89.5M+8.1%82.8M-28.9%117M-0.9%
Operating income792M+12.1%707M+13.0%625M+50.5%415M+117.0%191M+172.3%
Interest expense364M-6.4%389M-16.7%467M+21.4%385M-7.0%414M+6.2%
Interest & investment income22.5M-0.1%22.5M-24.6%29.8M+78.7%16.7M—
Pre-tax income430M+18.0%365M-35.3%564M+1093.6%47.2M+135.5%-133M+79.5%
Income tax104M+0.6%103M-11.6%116M+1280.6%8.43M+120.8%-40.6M+78.2%
326M+24.3%263M-61.1%674M+246.6%194M+314.1%-90.8M+80.3%
Income from continuing operations326M+24.3%263M-41.4%448M+1045.3%39.1M—
Discontinued operations0.000.00-100.0%226M+45.7%155M—
Net income to non-controlling interest476K+175.7%-629K-8.8%-578K-88.3%-307K+77.8%-1.39M-1574.5%
Net income to common326M+24.3%263M-61.1%674M+246.6%194M+314.1%-90.8M+80.3%
$1.22+23.2%$0.99-61.5%$2.57+242.7%$0.75+308.3%-$0.36+80.3%
EPS (basic)$1.24+24.0%$1.00-61.4%$2.59+240.8%$0.76+311.1%-$0.36+80.3%
Weighted-avg shares (basic)264M+0.3%263M+0.9%261M+1.3%257M+1.0%255M+1.2%
Weighted-avg shares (diluted)267M+0.4%266M+1.4%263M+1.4%259M+1.7%255M+1.2%
Dividends per share$0.42+10.5%$0.38-13.6%$0.44+0.0%$0.44+0.0%$0.44+0.0%
Balance Sheetas ofOct 3 ’25as ofSep 27 ’24as ofSep 29 ’23as ofSep 30 ’22as ofOct 1 ’21
3.52B+3.4%3.41B-34.7%5.22B+58.6%3.29B+13.6%2.90B-38.0%
Cash & equivalents639M-5.0%672M-65.1%1.93B+484.9%329M-38.1%533M-78.8%
Accounts receivable2.21B+5.4%2.10B+6.4%1.97B-8.2%2.15B+22.8%1.75B+22.2%
Inventory419M+8.0%388M-4.0%404M-26.9%552M+33.9%413M-5.5%
Prepaid expenses255M+2.0%250M-16.1%298M+13.5%262M+27.9%205M-31.4%
13.3B+5.0%12.7B-24.9%16.9B+11.9%15.1B+4.9%14.4B-8.5%
Property, plant & equipment1.73B+10.3%1.57B+10.3%1.43B-29.8%2.03B-0.3%2.04B-0.6%
Operating lease right-of-use702M+9.9%639M+11.6%572M-3.4%592M+0.7%588M+6.6%
Goodwill4.87B+4.2%4.68B+1.3%4.62B-16.3%5.52B+0.5%5.49B+2.7%
Intangible assets1.87B+3.8%1.80B+0.0%1.80B-14.6%2.11B+4.2%2.03B+5.0%
Other non-current assets597M+3.9%574M-21.2%729M-52.6%1.54B+15.1%1.34B+15.3%
3.55B-15.8%4.21B-16.2%5.03B+53.1%3.29B+15.0%2.86B+21.7%
Accounts payable1.52B+9.2%1.39B+9.6%1.27B-3.9%1.32B+43.9%919M+38.5%
Accrued liabilities1.39B+8.3%1.28B-0.4%1.29B+9.9%1.17B+3.3%1.14B+20.7%
Deferred revenue364M-1.8%371M+5.9%350M+0.9%347M+1.9%341M+16.8%
Short-term & current debt31.5M-96.7%964M-37.5%1.54B+2272.2%65.0M+10.5%58.9M-41.1%
Current lease liability60.7M+12.2%54.2M+5.6%51.3M-25.5%68.9M+2.3%67.3M-6.3%
Finance lease liability (current)—5.90M+57.2%3.75M-86.3%27.4M-1.4%27.8M-7.2%
———12.0B+3.4%11.6B-10.2%
Long-term debt5.37B+24.8%4.31B-15.5%5.10B-30.6%7.35B-0.6%7.39B-19.4%
Non-current lease liability255M+5.9%241M-2.0%246M-19.6%306M-2.8%314M-8.0%
Operating lease liability (total)316M+7.1%295M-18.7%363M-3.0%374M-1.9%382M-7.7%
Finance lease liability (total)59.2M+46.3%40.4M+26.6%31.9M-78.3%147M+0.7%146M+2.7%
Finance lease liability—34.5M+22.6%28.2M-76.5%120M+1.2%119M+5.3%
Deferred tax liabilities——610M+21.8%501M+30.8%383M-3.9%
Other non-current liabilities555M+13.3%490M-2.6%503M+109.1%241M-12.9%276M+31.1%
3.15B+3.6%3.04B-18.1%3.71B+22.5%3.03B+11.3%2.72B-0.5%
Common stock3.08M+1.2%3.04M+1.1%3.01M+1.2%2.98M+1.1%2.94M+1.2%
Additional paid-in capital4.04B+2.7%3.93B+2.8%3.83B+3.9%3.68B+4.2%3.53B+3.4%
Retained earnings453M+89.1%240M-75.1%964M+137.0%407M+24.2%328M-38.5%
Treasury stock1.18B+17.3%1.00B+2.2%982M+3.3%951M+1.9%933M+2.7%
Accumulated other comprehensive income-167M-26.4%-132M-34.8%-98.2M+12.0%-112M+46.4%-208M+32.3%
Total equity incl. non-controlling———3.03B+11.3%2.72B-0.5%
Total liabilities & equity13.3B+5.0%12.7B-24.9%16.9B+11.9%15.1B+4.9%14.4B-8.5%
Common shares issued308M+1.3%304M+1.1%301M+1.2%298M+1.1%294M+1.3%
Common shares outstanding263M-0.4%264M+1.0%261M+1.1%259M+1.1%256M+1.2%
Shares outstanding (cover)263M-0.4%264M+0.9%262M+1.1%259M+1.1%256M+1.1%
Treasury shares45.2M+12.0%40.3M+1.8%39.6M+2.0%38.8M+1.3%38.3M+1.9%
Cash Flowas ofOct 3 ’25as ofSep 27 ’24as ofSep 29 ’23as ofSep 30 ’22as ofOct 1 ’21
921M+26.8%727M+42.0%512M+10.3%464M-29.4%657M+271.9%
Depreciation & amortization476M+9.4%436M+6.3%410M+3.0%398M-27.7%551M-7.5%
Intangible amortization125M+16.3%107M+19.7%89.5M+8.1%82.8M-28.9%117M-0.9%
Share-based compensation58.6M-6.2%62.6M-18.1%76.3M-7.2%82.3M+15.8%71.1M+134.2%
Deferred income taxes14.2M+294.2%-7.32M-107.3%100M+529.6%15.9M+136.8%-43.2M+67.7%
Change in receivables74.5M-25.4%99.8M-43.9%178M-56.7%411M+41.6%290M+180.0%
Change in inventory24.1M+529.6%3.83M-89.2%35.3M-54.4%77.4M+927.5%7.54M-70.6%
Change in payables116M+9.2%106M-8.3%115M-70.6%392M—
Other operating activities28.9M-49.0%56.7M+4359.3%1.27M-87.9%10.5M-76.3%44.5M+446.2%
——209M+125.1%-831M-31.0%-634M-75.7%
Capital expenditure489M+14.5%427M+11.4%384M+22.9%312M-23.5%408M-2.6%
Free cash flow432M+44.4%299M+133.5%128M-15.7%152M-39.0%249M+203.1%
Acquisitions264M+77.2%149M+196.3%50.2M-84.5%323M+21.5%266M+1097.1%
Proceeds from sale of PP&E22.7M-5.3%23.9M+32.6%18.1M+10.6%16.3M-49.7%32.5M-39.9%
Other investing activities10.3M+175.3%3.76M+109.4%-40.1M-158.8%-15.5M-130.7%-6.72M+73.6%
——654M+1834.1%-37.7M+98.1%-2.01B-182.3%
Long-term debt issued1.97B+244.5%571M-55.6%1.29B+1185.9%100M-88.8%894M-72.4%
Long-term debt repaid0.000.000.000.000.00
Common stock issued43.0M+17.5%36.6M-19.8%45.6M+6.2%43.0M+3.3%41.6M-53.8%
Common stock repurchased170M+1079.8%14.4M-39.2%23.7M0.000.00-100.0%
Dividends paid111M+10.9%99.9M-12.8%115M+1.3%113M+1.0%112M+1.0%
Other financing activities-9.13M+76.2%-38.4M-315.8%17.8M+139.4%-45.1M+24.5%-59.7M+33.6%
FX effect on cash10.5M-2.2%10.8M+129.7%4.70M+116.4%-28.7M-573.7%6.05M-36.1%
Net change in cash-25.5M+97.9%-1.24B-175.5%1.64B+841.1%-222M+88.8%-1.98B-187.4%
Interest paid329M-1.4%334M-18.3%408M+24.2%329M-11.1%370M+4.6%
Income taxes paid117M+0.3%116M+152.6%46.0M+277.0%12.2M+111.6%-105M-360.9%
Valuation Ratiosas ofOct 3 ’25as ofSep 27 ’24as ofSep 29 ’23as ofSep 30 ’22as ofOct 1 ’21
Market cap10.3B+1.1%10.1B+54.9%6.55B+12.4%5.83B-11.9%6.61B+31.4%
P/E31.4×-18.7%38.6×+297.7%9.7×-67.6%30.0×—
P/S0.6×-5.0%0.6×+43.2%0.4×-4.4%0.4×-22.1%0.5×+39.4%
P/B3.3×-2.4%3.3×+89.2%1.8×-8.3%1.9×-20.8%2.4×+32.0%
P/FCF23.7×-30.0%33.9×-33.7%51.1×+33.3%38.4×+44.6%26.5×
Earnings yield3.2%+23.0%2.6%-74.9%10.3%+208.4%3.3%—
FCF yield4.2%+42.9%2.9%+50.7%2.0%-25.0%2.6%-30.8%3.8%
Dividend yield1.1%+8.9%0.99%-43.7%1.8%-10.1%2.0%+14.7%1.7%-23.0%
Source filing10-K10-K10-K10-K10-K
Fiscal yearCEOTotal, as reportedActually paidOther executives, average$100 in the stock$100 in peers
FY2025—$18.7M$24.2M$3M$193.00$134.00
FY2024—$12.7M$17.6M$2.8M$126.00$99.00
FY2023—$13.3M$11.5M$3.2M$113.00$85.00
FY2022—$5.1M$17.2M$1.7M$130.00$121.00
FY2021—$5.1M$17.2M$1.7M——

From the pay-versus-performance table of each proxy statement (DEF 14A), the newest that states the year. “Actually paid” values stock awards at the year’s closing price, so it falls when the stock does. A year two chief executives shared lists each one’s pay, as reported / actually paid, and the totals are both. $100 in the stock and in the peer group the proxy names are the newest proxy’s, from the start of its first year.

About this data

Source: ARMK’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ARMK filings on SEC EDGAR → Not investment advice.